NasdaqCM - Nasdaq Real Time Price USD

eXoZymes, Inc. (EXOZ)

13.53

+1.74

+(14.76%)

At close: April 23 at 4:00:01 PM EDT

13.53

0.00

(0.00%)

After hours: April 23 at 4:05:07 PM EDT

Bringing clarity and precision to the cell-free space by introducing exozymes

Dr. Tyler Korman, co-founder and VP of Research at eXoZymes, is excited about the 'exozymes' cover story in GEN Biotechnology, which is freely available as an Open Access paper Dr. Tyler Korman, co-founder and VP of Research at eXoZymes, is excited about the 'exozymes' cover story in GEN Biotechnology, which is freely available as an Open Access paper Scientific definition of exozymes featured as cover story in GEN Biotechnology, freely available as an Open Access paper The author team introduce

GlobeNewswire 2 days ago

EXOZ
+14.76%
New to The Street's FOX Business "Late Night T.V." Special Airs Tonight – Show #650 – Featuring Health In Tech CEO Julia Qian (NASDAQ:HIT), BioVie's Dr. Joseph Palumbo (NASDAQ:BIVI), eXoZymes Co-Founder & VP of Research Tyler Korman (EXOZ), and ARRIVE AI Founder & CEO Dan O'Toole (ARAI)

Also debuting - our hospitality segment featuring BLACKBARN NYC with Chef John Doherty and a spotlight on The Sustainable Green Team (OTC PINK:SGTM) with Kevin Harrington and CEO Tony Raynor NEW YORK, NY / ACCESS Newswire / April 14, 2025 /New to ...

ACCESS Newswire 9 days ago

SGTM

BIVI

HIT
BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant

Monrovia, CA, April 10, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into nutraceuticals, medicines, and other essential chemicals - announced its latest initiative - BioClick - a pioneering concept designed to enhance and accelerate the engineering of enzymes for advanced chemical reactions. Funded in part by a $300K grant from the National Institutes of Health (NIH), this project has the

GlobeNewswire 13 days ago

EXOZ
+14.76%
eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO

Expanded leadership team as eXoZymes ramps up commercial growth Damien Perriman brings more than two decades of experience in successfully developing and commercializing novel biotechnologies Focus on developing commercial opportunities, spin-outs, joint-ventures, and licensing deals with future partners Monrovia, CA, April 02, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential che

GlobeNewswire 21 days ago

EXOZ
+14.76%
eXoZymes Provides Fourth Quarter and Full Year 2024 Update

Management to Host Conference Call Today at 4:30PM Eastern Monrovia, CA, April 02, 2025 (GLOBE NEWSWIRE) -- Today, eXoZymes Inc. (NASDAQ: EXOZ) (“eXoZymes”) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential nutraceuticals, medicines, biofuels, and other valuable chemicals - provides an update on operations through the fiscal year ended December 31, 2024. Michael Heltzen, CEO of eXoZymes, states, “As a pre-revenue company, what’s important for us is that

GlobeNewswire 21 days ago

EXOZ
+14.76%
eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025

Monrovia, CA , March 26, 2025 (GLOBE NEWSWIRE) -- eXoZymes Inc. (NASDAQ: EXOZ) [“eXoZymes”] - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential chemicals, medicines, and biofuels - plans to host a webinar on Wednesday, April 2, 2025 at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter and full year 2024. A press release detailing these results will be issued prior to the call. Michael Heltzen, CEO of eXoZymes will lead the call and will

GlobeNewswire 28 days ago

EXOZ
+14.76%
New to the Street Airs Show #630 on Fox Business Network Tonight at 10:30 PM PST Featuring Roadzen ($RDZN), BioVie ($BIVI), AtlasClear (ATCH), eXoZymes ($EXOZ), and EvolveHealthandLifestyle.com With Craig Bruce

Also Featuring The Sustainable Green Team ($SGTM) with Shark Tank’s Kevin Harrington Showcasing Their WaterLess Garden Product NEW YORK CITY, NY / ACCESS Newswire / March 3, 2025 /New to The Street, a leading financial news and business television ...

ACCESS Newswire last month

BIVI

ATCH

ATCHW
eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.

Monrovia, CA, Feb. 21, 2025 (GLOBE NEWSWIRE) -- eXoZymes Inc. (NASDAQ: EXOZ, formerly Invizyne Technologies) - a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential chemicals, medicines, and biofuels - and MDB Capital Holdings (NASDAQ: MDBH) - a premier venture platform for breakthrough technology companies - today announced key leadership changes within the eXoZymes board of directors. Mo Hayat has transitioned out of his roles as Chairman of the Board and P

GlobeNewswire last month

EXOZ
+14.76%
eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering

Monrovia, CA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- eXoZymes, Inc. (Nasdaq: EXOZ) (“eXoZymes”) – a pioneer of AI-engineered enzymes that can transform sustainable feedstock into essential chemicals, medicines, and biofuels – today announced that CEO Michael Heltzen will be joined by eXoZymes team members to ring the Nasdaq Stock Market (“Nasdaq”) closing bell on Wednesday, February 19, 2025. This comes following a successful initial public offering of common stock at $8 per share, which closed on No

GlobeNewswire 2 months ago

MDBH
+0.22%
EXOZ
+14.76%
Institutional investors own a significant stake of 42% in Invizyne Technologies, Inc. (NASDAQ:IZTC)

Key Insights Given the large stake in the stock by institutions, eXoZymes' stock price might be vulnerable to their...

Simply Wall St. 2 months ago

EXOZ
+14.76%
IZTC
Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes

Rebranding Invizyne Technologies, Inc to eXoZymes Inc.Changing NASDAQ ticker from IZTC to EXOZIntroducing but not trademarking “exozymes” as a new scientific nomenclature Monrovia, California, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Today, Invizyne Technologies, Inc. - a pioneer of AI-engineered enzymes that can sustainably transform feedstock into essential chemicals, medicines, and biofuels, announced a corporate name change to eXoZymes, Inc. (“eXoZymes”) and that its common stock will begin trading

GlobeNewswire 2 months ago

MDBH
+0.22%
IZTC

Performance Overview

Return	EXOZ	S&P 500 (^GSPC)
YTD	-18.00%	-8.60%
1-Year	+21.89%	+6.02%
3-Year	+21.89%	+25.85%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

eXoZymes, Inc. (EXOZ)

Bringing clarity and precision to the cell-free space by introducing exozymes

New to The Street's FOX Business "Late Night T.V." Special Airs Tonight – Show #650 – Featuring Health In Tech CEO Julia Qian (NASDAQ:HIT), BioVie's Dr. Joseph Palumbo (NASDAQ:BIVI), eXoZymes Co-Founder & VP of Research Tyler Korman (EXOZ), and ARRIVE AI Founder & CEO Dan O'Toole (ARAI)

BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant

eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO

eXoZymes Provides Fourth Quarter and Full Year 2024 Update

eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025

New to the Street Airs Show #630 on Fox Business Network Tonight at 10:30 PM PST Featuring Roadzen ($RDZN), BioVie ($BIVI), AtlasClear (ATCH), eXoZymes ($EXOZ), and EvolveHealthandLifestyle.com With Craig Bruce

eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc.

eXoZymes Announces Nasdaq Bell Ringing to Commemorate Initial Public Offering

Institutional investors own a significant stake of 42% in Invizyne Technologies, Inc. (NASDAQ:IZTC)

Rebranding Invizyne to eXoZymes Signifies a Sustainable Paradigm Shift in Chemical Production Leveraging AI-Engineered Enzymes

Performance Overview